Search
Bausch Health Companies Inc
BHCAdd to Watchlist
4.770USD
-0.160-3.25%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
1.84BMarket Cap
LossP/E TTM
More Details of Bausch Health Companies Inc Company
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Bausch Health Companies Inc Info
Ticker SymbolBHC
Company nameBausch Health Companies Inc
IPO dateSep 20, 1994
CEOAppio (Thomas J)
Number of employees20700
Security typeOrdinary Share
Fiscal year-endSep 20
Address2150 St. Elzear Blvd. West
CityLAVAL
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryCanada
Postal codeH7L 4A8
Phone18003611448
Websitehttps://www.bauschhealth.com/
Ticker SymbolBHC
IPO dateSep 20, 1994
CEOAppio (Thomas J)
Company Executives of Bausch Health Companies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
367.93K
+27.24%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
300.59K
+15.26%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
186.40K
-136.49%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
90.22K
+50.84%
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
76.02K
+60.34%
Ms. Aimee J. Lenar
Ms. Aimee J. Lenar
Executive Vice President, US Pharma
Executive Vice President, US Pharma
43.91K
-275.67%
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Dr. Richard C. Mulligan, Ph.D.
Dr. Richard C. Mulligan, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Appio
Mr. Thomas J. Appio
Chief Executive Officer, Director
Chief Executive Officer, Director
903.22K
-173.57%
Dr. Amy B. Wechsler, M.D.
Dr. Amy B. Wechsler, M.D.
Independent Director
Independent Director
367.93K
+27.24%
Mr. Robert N. Power
Mr. Robert N. Power
Independent Director
Independent Director
300.59K
+15.26%
Mr. Jean-Jacques (JJ) Charhon
Mr. Jean-Jacques (JJ) Charhon
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
186.40K
-136.49%
Ms. Sandra Leung
Ms. Sandra Leung
Director
Director
90.22K
+50.84%
Mr. Michael Goettler
Mr. Michael Goettler
Director
Director
76.02K
+60.34%
FAQs
Who are the top five shareholders of Bausch Health Companies Inc?
The top five shareholders of Bausch Health Companies Inc are: Mr. Thomas J. Appio
How many institutions hold shares of Bausch Health Companies Inc (BHC)?
As of 2026Q1, 510 institutions hold shares of Bausch Health Companies Inc, with a combined market value of approximately 173.34M, accounting for 46.41% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -64499603.00.
What is the biggest source of revenue for Bausch Health Companies Inc?
In 2026Q1, the Pharmaceutical Products business generated the highest revenue for Bausch Health Companies Inc, amounting to 4.75B and accounting for 46.24% of total revenue.